Highlights BiVictriX Therapeutics Plc

Equities

BVX

GB00BNXH3K91

Market Closed - London S.E. Other stock markets 09:05:28 20/05/2024 pm IST			5-day change	1st Jan Change
10 ^GBX	-13.04%		-13.04%	-4.76%

17/04	Bivictrix granted FDA orphan drug status for rare cancer treatment	AN
17/04	BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment	17/04	MT
Bivictrix selects final sequences for lead tumour programme	30/11	AN
BiVictriX Therapeutics plc Announces Pipeline Update on Lead Solid Tumour Programme, Bvx002	30/11	CI
BiVictriX patent boost; 4Global deal extended	15/11	AN
BiVictriX Obtains Japanese Patent for Acute Myeloid Leukemia Drug Conjugate	15/11	MT
Bivictrix says BVX001 increases survival rates by more than double	12/23/12	AN
BiVictriX Therapeutics Plc Announces Chief Financial Officer Changes	03/23/03	CI
BiVictriX Therapeutics Plc Appoints Adrian Howd as Chief Business Officer	03/23/03	CI
AEW UK REIT appoints new chair; Oberon raises money	19/23/19	AN
Earnings Flash (BVX.L) BIVICTRIX THERAPEUTICS Posts H1 Loss GBX-1.77	19/23/19	MT
BiVictriX Therapeutics Plc Reports Earnings Results for the Half Year Ended June 30, 2023	19/23/19	CI
Bivictrix Therapeutics granted US patent for cancer drug BVX001	23/23/23	AN
BiVictriX Therapeutics Secures US Patent for Lead Asset	23/23/23	MT
EARNINGS UPDATES: Ironveld sees interim pretax loss widen on costs	30/23/30	AN
Earnings Flash (BVX.L) BIVICTRIX THERAPEUTICS Reports FY22 Loss GBX-3.78	30/23/30	MT
BiVictriX Therapeutics Plc Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
TRADING UPDATES: Bivictrix hails cancer therapy candidate	31/23/31	AN
BiVictriX Therapeutics Plc Announces Positive Data from Preclinical Study of BVX001	31/23/31	CI
AIM WINNERS & LOSERS: Bivictrix surges on lead for BVX001 programme	07/22/07	AN
Bivictrix identifies lead for antibody drug conjugates programme	07/22/07	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BiVictriX Therapeutics Plc

Equities

BVX

GB00BNXH3K91

Highlights

Filters